Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05059535Phase 4Terminated
Phase 4, randomised, open-label trial (3 arms), sponsored by Ramsay Santé. Primary endpoint: 90° flexion pain at 2 days. Started Jan 2022; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05059535.